DIFFINITY GENOMICS INC
- Headquarters
- West Henrietta, NY
- Latest Form D
- $678K, Mar 2012
- Total capital
- $3.3M
- Federal grants
- $2M
- 8 awards · 2008–2012
- Private capital raised
- $1.4M
- 2 Form D · last Mar 2012
- 175 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 2 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Rapid intercalator removal from size-selected DNA for next generation sequencing$100K
- Private capital raisedForm D · SEC · 2nd filing$678K
- Federal grantHealth and Human S · Phase II · Rapid purification following enzyme-catalyzed nucleic acid reactions$146K
- Federal grantHealth and Human S · Phase I · Rapid purification following enzyme-catalyzed nucleic acid reactions$104K
- Federal grantHealth and Human S · Phase I · Rapid DNA extraction from gels$102K
- Federal grantHealth and Human S · Phase II · Rapid purification following enzyme-catalyzed nucleic acid reactions$604K
- Federal grantHealth and Human S · Phase II · Rapid purification following enzyme-catalyzed nucleic acid reactions$109K
- Private capital raisedForm D · SEC · 1st filing$680K
Show 2 earlier federal awards
- Federal grantHealth and Human S · Phase II · Rapid and Efficient PCR Cleanup Filters$717K
- Federal grantHealth and Human S · Phase I · Rapid and Efficient PCR Cleanup Filters$106K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
33months
from DIFFINITY GENOMICS INC’s first federal award to its first private round.
- First federal award · May 2008
- Health and Human S · $106K
- First Form D · Feb 2011
- $680K · 1st Form D
- Awards before first raise
- 2 awards
An association in public records, not a cause or a prediction.
Founders and team
Researcher links verified by same-company patents and grants- Lewis Josiah RothbergResearcherExecutive Officer, Director, PromoterLinked by $2M in grants as PI
- Jeffrey L. HelferExecutive Officer, DirectorNamed in SEC Form D filings
- John Allen FoskettDirectorNamed in SEC Form D filings
- Michael Dean RiedlingerDirectorNamed in SEC Form D filings
- Robert Allen EvansDirectorNamed in SEC Form D filings
- Robin Joan HodownesExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 2- PendingDisposable Functional Pipette Tips For The Isolation Of Nucleic AcidsUSPTOApplication PCTUS2013054149
- PendingSystem And Methods For Purifying Biological MaterialsUSPTOApplication PCTUS2010024201
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .